BIOTECH BY THE LAKE 2021
INVESTOR SUMMIT
Tuesday, June 22, 2021
9:00 – 11:45 a.m. Central Time (CST)
(7:00 – 9:45 a.m. Pacific; 8:00 – 10:45 a.m. Mountain; 10:00 – 12:45 p.m. Eastern)
BIOTECH BY THE LAKE 2021 INVESTOR SUMMIT
The third annual Biotech by the Lake Investor Summit will provide an exclusive look at next-generation neurological disorder therapies and breakthroughs developed by Chemistry of Life Processes Institute’s top translational scientists. The virtual summit will bring together Northwestern academic innovators, investment experts and biotech/pharma industry leaders. Presentations and panel discussions will focus on latest developments, hottest trends in neuroscience research and investment opportunities within Chicago’s growing biotech community and beyond.
PROGRAM
NORTHWESTERN FACULTY PRESENTERS
9:00 a.m. (CST) - Welcome and Introduction
Neil L. Kelleher, PhD
Walter and Mary E. Glass Professor of Molecular Biosciences; Professor of Chemistry, Weinberg College of Arts Sciences; Professor of Medicine (Hematology & Oncology), Feinberg School of Medicine; Director, Northwestern Proteomics; and Director, Chemistry of Life Processes Institute, Northwestern University
9:05 a.m. (CST) - Improving the Success Rate of Clinical Trials by Proteomics
Pembe Hande Ozdinler, PhD
Associate Professor of Neurology, Feinberg School of Medicine; Member, Chemistry of Life Processes Institute, Northwestern University
9:25 a.m. (CST) - Next Generation Vaccines Targeting the Cause of Alzheimer’s Disease
William Klein, PhD
Professor of Neurobiology Weinberg College of Arts and Sciences; Member, Chemistry of Life Processes Institute, Northwestern University
9:45 a.m. (CST) - High Precision Screens for Pharmacological Traction of Neuroplasticity
Yevgenia Kozorovitskiy, PhD Soretta and Henry Shapiro Research Professor of Molecular Biology, Associate Professor of Neurobiology Weinberg College of Arts and Sciences; Member Chemistry of Life Processes Institute, Northwestern University
10:05 a.m. (CST) - Upper Motor Neuron Diseases and Alzheimer’s: Serious Diseases Addressed in the Silverman Group
Richard B. Silverman, PhD
Patrick G. Ryan/Aon Professor; Professor of Chemistry and Molecular Biosciences, Weinberg School of Arts and Sciences; Member, Chemistry of Life Processes Institute, Northwestern University
PANEL DISCUSSION: HOT TOPICS IN NEUROLOGICAL DISORDER THERAPEUTICS AND TECHNOLOGIES
10:25 a.m. (CST)
Moderator:
Lauren Martz
Senior Editor, Head, Translation and Clinical Development
BioCentury Inc.
Panelist:
Sarah Bhagat, PhD
General Partner
Sofinnova Investments
Panelist:
Ginger S. Johnson, PhD
Chief Executive Officer
Cello Health BioConsulting
Panelist:
Norbert Riedel, PhD
Chief Executive Officer
Aptinyx Inc.
Panelist:
Myung Shin, PhD
Executive Director and Head of Early Discovery Genetics
Genetics and Pharmacogenomics
Merck & Co., Inc.
CORPORATE PRESENTERS:
10:45 a.m. (CST)
Sean M. Smith, PhD
Executive Director of Neuroscience Discovery
Merck & Co.
11:05 (CST)
Casper Hoogenraad, PhD
Vice President, Head of Neuroscience Research
Genentech
PANEL DISCUSSION: FINANCING AND INVESTING IN NEUROLOGICAL SCIENCE BIOTECH
11:25 a.m.
Moderator:
Jay Olson, CFA
Research Analyst
Oppenheimer & Co.
Panelist:
Jamil M. Beg
Partner
5AM Ventures
Panelist:
Margarita Chavez, JD
Managing Director
AbbVie Ventures
Panelist:
Michael Margolis, R Ph
Managing Director
Oppenheimer & Co.
Panelist:
Jingwen Wang, PhD
Portfolio Manager
Verition Fund Management, LLC
11:45 a.m. - Event Concludes
Acknowledgement
We would like to express our gratitute to the members of the Chemistry of Life Processes Institute’s Executive Advisory Board (EAB) for their enthusiastic support for the Biotech by the Lake Investor Summit series. Our special thanks to EAB member Sujal Shah, President and CEO of CymaBay Therapeutics (CBAY), whose vision, guidance and leadership made this investor series possible.
